Product categories Resources Company Contact For investors For distributors Subscribe to our latest news & articles Email* I have read and agree to Devyser's privacy policy. Knowledge hub Join us here for a closer look at the news, research and trends shaping the diagnostic landscape. ‍ ‍ ‍ ‍ Filter by All Transplantation Thalassemias Oncology Fetal RHD screening NIPT Hereditary Cystic fibrosis Cardiovascular Male infertility Rapid aneuploidy analysis Insights Technology Insights Transplantation Chimerism monitoring: is there a new gold standard on the horizon? NGS technology is enabling improved chimerism monitoring, with novel strategies that combine the benefits of STR-PCR and qPCR into a single assay. Insights Fetal RHD screening NIPT Literature review - NIPT for fetal RHD status using an exon 4-based assay We summarize the findings of three seminal publications that support clinical implementation of the single-exon detection strategy for fetal RHD screening. Insights Fetal RHD screening NIPT RHD screening just got easier: how single exon NIPT testing helps In RhD-negative mothers, anti-D prophylaxis can be withheld if the fetus is also RhD-negative. Fetal RHD status testing with NIPT is efficient and low risk. Insights Fetal RHD screening NIPT Prevent RhD disease without overtreatment: how NIPT optimizes administration Non-invasive prenatal testing (NIPT) can help us determine fetal RhD status without a drop of fetal blood. Learn more. Technology Thalassemias Guide to NGS test implementation - simpler, faster, better This NGS guide addresses frequently asked questions and highlights key factors to consider when adding a new NGS test to your offering. Insights Thalassemias Genetic testing for alpha and beta thalassemia testing just got a lot easier. One patient – one reaction Next-generation sequencing (NGS) testing can be used for simultaneous analysis of HBA and HBB gene clusters. Insights Thalassemias Alpha- and beta-thalassemia – can one test meet all needs? Difference between alpha- & beta-thalassemia testing, as well as new technologies to determine thalassemia variants that can reduce turnaround time. Technology Thalassemias The NGS workflow These are the traditional four steps in an NGS workflow - nucleic acid extraction, library preparation, sequencing, data analysis. Technology Thalassemias NGS testing in clinical practice - what to expect Staffing requirements, breadth of assay technologies, assessing the impact on workflows Case study Transplantation A new NGS-based method for chimerism monitoring New, highly sensitive and precise methods for mixed chimerism analytics Insights Thalassemias Challenges in Thalassemia diagnosis Thalassemia is typically caused by sequence variants in the HBA1, HBA2 or HBB genes. Product update Transplantation Devyser launches first NGS-based test for mixed chimerism Devyser Chimerism is an NGS library kit which enables both screening and monitoring using a single reaction mix. Whitepaper Oncology Easily identify BRCA1 and BRCA2 genetic mutations Read more about simple identification of both BRCA1 and BRCA2 genes in the whitepaper Insights Rapid aneuploidy analysis Principles of QF-PCR QF PCR analysis includes amplification, detection and analysis of chromosome-specific DNA sequences known as genetic markers or small tandem repeats (STRs). Insights Rapid aneuploidy analysis STR markers A short tandem repeat (STR or microsatellite) is a pattern of two or more nucleotides that are repeated directly adjacent to each other. Next 15 Items 1 / 2 Results for life. Product categories Transplantation Thalassemias Oncology Fetal RHD screening NIPT Hereditary Cystic fibrosis Cardiovascular Male infertility Rapid aneuploidy analysis Accessories Resources Knowledge hub Whitepapers Tools IFU & certificates Company About us Teams Career News and events Privacy policy About cookies Contact Contact us Our offices Support Distributors © Devyser 2021